S-1 · primary offering
Issued 2024
Proposed maximum
Shares registered
- Filed
- Effective
BBLG$0.3705-0.09%
Bone Biologics Corp
Sector: Orthopedic, Prosthetic & Surgical Appliances & SuppliesIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$1.26M
Float & O/S:
Inst Own:
DilutionScan read 32 of Bone Biologics Corp's SEC filings and found 17 warrant series, 1 ATM program, 5 shelf registrations, 2 S-1 registrations and 1 completed offering on file for BBLG. The latest dilution event on file is ATM sales on Sep 30, 2026. Analysis updated Oct 26, 2026.
Signal8 Summary
BBLG
Going-concern warning from auditors
Snapshot
BBLG is a pre-revenue micro-cap developing a bone regeneration device for spinal fusion. The company has generated zero revenue over the last three years and posted a $3.1M net loss in FY 2025.
What's Happening Right Now
- : The validated shelf life of the rhNELL-1 protein was extended to 32 months to support manufacturing and distribution for the upcoming pivotal study.
- : The company secured $3.0 million in gross proceeds from a private placement, which it states extends its operational runway through Q2 2027.
- : Auditors issued a going-concern warning expressing substantial doubt about the company's ability to continue as a going concern within one year.
Raise routes on file: active ATM + effective shelf · latest dilution event 34 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Sep 30, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Completed
S-1 · primary offering
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
October 2021 warrants
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
October 2022 warrants
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
October 2022 warrants
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
October 2022 warrants
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
November 2023 investor warrants
Issued 2023
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
November 2023 placement agent warrants
Issued 2023
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
ATM program
Issued 2024
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
S-3 shelf registration
Issued 2025
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2022
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
PIPE
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your BBLG trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
